The Life Science Institute (LSI) Centre for Genomic Health (CGH) unites the wealth of genomic expertise around Queen Mary to tackle some of the key roadblocks in the field.
About
The Centre for Genomic Health (CGH) has active links with many national initiatives in genomics and big data such as the Farr Institute, the UK Biobank, and the Digital Health innovations, and is leading many international efforts on common and rare disease genomics. There is strong research interest in cancer genomics including genetic predisposition, cancer evolution and precision medicine.
The CGH is led by Professor Vardhman Rakyan (Blizard Institute), with co-leads Professor Mark Caulfield (William Harvey Research Institute) and Professor David van Heel (Blizard Institute). The CGH prioritises promoting interactions between members of the genomic community both within QMUL and externally, as well as with the broader Life Sciences community, with the aim to foster new joint work which might not otherwise take place. At present we are in particular working with the LSI Centre for Computational Biology.
Our expertise in Genomics is coupled with world-class Epigenetics. The CGH has strong links to Genomics England and East London Genes and Health (ELGH) and the QMUL Epigenetics Hub, with members across these organisations.
Learn more about our research.
